{
    "2021-01-13": [
        [
            {
                "time": "2018-03-15",
                "original_text": "AbbVie (ABBV) Inks Deal to Acquire Medical Device Company",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "deal",
                        "acquire",
                        "medical device"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "These 3 Value Stocks Are Absurdly Cheap Right Now",
                "features": {
                    "keywords": [
                        "value stocks",
                        "cheap"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Harpoon Therapeutics Granted Orphan Drug Designation from FDA for HPN217 for Treatment of Multiple Myeloma",
                "features": {
                    "keywords": [
                        "Harpoon Therapeutics",
                        "orphan drug",
                        "FDA",
                        "HPN217",
                        "multiple myeloma"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "3 Dividend Aristocrats to Buy Right Now",
                "features": {
                    "keywords": [
                        "dividend aristocrats",
                        "buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}